Osaka, Japan

Atsushi Kuno


Average Co-Inventor Count = 4.0

ph-index = 5

Forward Citations = 66(Granted Patents)


Location History:

  • Mino, JP (1987 - 1988)
  • Toyono-gun, JP (1998)
  • Osaka, JP (1989 - 2000)

Company Filing History:


Years Active: 1987-2000

Loading Chart...
12 patents (USPTO):Explore Patents

Title: **The Innovative Patents of Atsushi Kuno**

Introduction

Atsushi Kuno, an accomplished inventor from Osaka, Japan, has made significant contributions to the field of medicinal chemistry. With a repertoire of 12 patents, Kuno has focused on developing innovative compounds that have promising applications in the medical field. His work is notable not only for its creativity but also for its potential impact on healthcare.

Latest Patents

Among his latest achievements, Kuno has patented a series of guanidine derivatives, including benzoylguanidine derivatives, which show considerable promise as effective medicaments. These innovations highlight his dedication to enhancing therapeutic options and address various health issues.

Career Highlights

Atsushi Kuno has had a noteworthy career, primarily associated with Fujisawa Pharmaceutical Company, Ltd. and Fujisawa Pharmaceutical Co., Ltd. His work within these prestigious organizations has allowed him to delve into research and development, furthering his expertise in pharmaceuticals.

Collaborations

Throughout his career, Kuno has collaborated with talented colleagues such as Hisashi Takasugi and Takao Takaya. These partnerships have likely enriched his research endeavors and contributed to the successful development of several patents.

Conclusion

In summary, Atsushi Kuno stands out as a prominent inventor in the pharmaceutical arena. His robust patent portfolio, characterized by innovative compounds like guanidine derivatives, showcases his impactful contributions to medicine. As he continues to explore new horizons in research, Kuno's work will likely inspire future advancements in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…